GLP-1 analogs are synthetic peptides that replicate the function of glucagon-like peptide-1, a key incretin hormone involved in glucose regulation, appetite signaling, and insulin secretion. These compounds are frequently studied in metabolic research models related to insulin sensitivity, glycemic control, and weight modulation.
Common analogs such as Semaglutide, Tirzepatide, and Retatrutide exhibit distinct receptor activity across GLP-1, GIP, or dual pathways—making them central tools in endocrine and obesity-related studies.
All peptides in this category are intended strictly for laboratory research use and are independently verified for ≥99% purity by Vanguard Laboratories using HPLC and Mass Spectrometry.
